Analyst firms · Imperial Capital · HIMS
Imperial Capital HIMS price target and rating history
Hims & Hers Health Inc. (HIMS) · Health Care
Imperial Capital rates Hims & Hers Health Inc. (HIMS) In-line with a $16 price target, as of its latest action on Aug 9, 2024. It has published 3 rating actions on HIMS since December 2023, including 1 upgrade and 1 downgrade. Across 5 firms with a HIMS price target in the last 12 months, the median target is $33.
- Current rating
- In-line
- Price target
- $16
- Median target, all firms
- $33
- Actions on HIMS
- 3
Imperial Capital price target on HIMS
Every Imperial Capital rating on HIMS
- Aug 9, 2024
- Feb 28, 2024
- Dec 7, 2023
How other firms rate HIMS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Needham | Buy | $35 | May 12, 2026 |
| Citigroup | Neutral | $24 | Mar 10, 2026 |
| BofA Securities | Neutral | $23 | Mar 10, 2026 |
| BTIG | Neutral | Feb 24, 2026 | |
| Evercore ISI | In-line | $33 | Jan 12, 2026 |
| Barclays | Overweight | $48 | Dec 9, 2025 |
Questions about Imperial Capital and HIMS
- What is Imperial Capital's price target for HIMS?
- Imperial Capital's latest stated price target for Hims & Hers Health Inc. (HIMS) is $16, from its action on Feb 28, 2024.
- What is Imperial Capital's rating on HIMS?
- Imperial Capital rates HIMS In-line, a neutral rating, as of Aug 9, 2024.
- When did Imperial Capital last change its view on HIMS?
- On Aug 9, 2024, Imperial Capital downgrades to In-line from Outperform.
- How does Imperial Capital's HIMS target compare with other analysts?
- Across 5 firms with a HIMS price target in the last 12 months, the median target is $33.
More HIMS rating histories
All Imperial Capital ratingsHIMS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.